ClinicalTrials.gov
ClinicalTrials.gov Menu

To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01023685
Recruitment Status : Completed
First Posted : December 2, 2009
Last Update Posted : June 26, 2013
Sponsor:
Information provided by (Responsible Party):
Novartis

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2012
  Actual Study Completion Date : February 2012